- , Friday, September 6, 2002 12 AM
The U.S. Food and Drug Administration's crackdown on misleading advertising took aim at some of the pharmaceutical industry's top-selling drugs last month, according to warning letters posted on the
agency's website late on Wednesday.
Read the whole story at »